ClariVest Asset Management’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
CCM
GC
ACM
ClariVest Asset Management's TECX Position: Q2 2021 in Review
ClariVest Asset Management sold out of Tectonic Therapeutic (TECX) in Q2 2021, closing a stake of 1,933 shares — an estimated $294K sold.
ClariVest Asset Management first reported a position in TECX in Q2 2020 and held it in 4 quarters. The position peaked at $338K in Q2 2020. 97 funds tracked by Wall St. Rank hold TECX as of Q2 2021.
- ClariVest Asset Management reported no remaining Tectonic Therapeutic position as of Q2 2021 after selling out during the quarter.
- ClariVest Asset Management sold 1,933 Tectonic Therapeutic shares in Q2 2021, an estimated $294K.
- ClariVest Asset Management first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 4 quarters.
- ClariVest Asset Management's Tectonic Therapeutic position peaked at $338K in Q2 2020.
- 97 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2021.
Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.